DOI QR코드

DOI QR Code

Role of Iridin Isolated from Iris koreana Nakai on Doxorubicin-induced Necrosis in HK-2 Cells, and Effect on Cancer Cells

노랑붓꽃에서 분리된 Iridin의 독소루비신 유도 HK-2 세포 괴사에 대한 역할 및 암세포에 대한 작용

  • Nho, Jong Hyun (National Development Institute of Korean Medicine) ;
  • Lee, Ki Ho (National Development Institute of Korean Medicine) ;
  • Jung, Ho Kyung (National Development Institute of Korean Medicine) ;
  • Lee, Mu Jin (National Development Institute of Korean Medicine) ;
  • Jang, Ji Hun (National Development Institute of Korean Medicine) ;
  • Sim, Mi Ok (National Development Institute of Korean Medicine) ;
  • Jung, Ja Kyun (National Development Institute of Korean Medicine) ;
  • Jung, Da Eun (National Development Institute of Korean Medicine) ;
  • Cho, Hyun Woo (National Development Institute of Korean Medicine)
  • Received : 2017.08.07
  • Accepted : 2017.12.12
  • Published : 2018.04.30

Abstract

Doxorubicin is a anti-cancer drugs that interferes with the growth and spread of cancer cells in human body. Doxorubicin is used to treat different types of cancers that affect the ovary, thyoid and lungs, but induced side effect such as nephrotoxicity and cardiotoxicity. Thus, we investigated that the effect of iridin on doxorubicin-induced necrosis in HK-2 cells, a human proximal tubule cell. To confirm effect of iridin on doxorubicin-induced necrosis, HK-2 cells are treated with $10{\mu}M$ doxorubicin and $80{\mu}M$ iridin. $80{\mu}M$ iridin reduced $10{\mu}M$ doxorubicin-induced necrosis, the mitochondrial over activation and caspase-3 activation. However, iridin reduces anti-cancer effect of doxorubicin such as PARP1 and caspase-3 activation, checkpoint proteins (CDK4 and CDK6) in NCI-H1129 cells (Human non-small cell lung cancer cell). In HCT-116 cells (Human colorectan cancer cell), iridin do not increased protein expression of CDK4 and CDK6 decreased by doxorubicin. Results indicate that treatment of iridin was diminished doxorubicin-induced necrosis in HK-2 cells. However, iridin was decreased anti-cancer effect of doxorubicin on NCI-H1229, but not HCT-116. Thus, further experiment are required to iridin treatment on various cancer cells and animal models because effect of iridin different cell type.

노랑붓꽃에서 분리된 iridin의 doxorubicin으로 유도된 신장 세포괴사 모델에 대한 보호 효과 및 암세포에 대한 작용을 알아보기위해 연구를 수행하였다. Iridin 단일 처리로는 신장근위세뇨관 세포주에 대해 독성을 나타내지 않았으며, $80{\mu}M$의 농도에서 $10{\mu}M$ doxorubicin 처리에 의한 세포사멸을 $94.6{\pm}2.6%$까지 회복시켰다. 또한 $80{\mu}M$ iridin 처리는 $10{\mu}M$ doxorubicin 처리에 의해 증가된 cleaved PARP1과 cleaved caspase-3를 포함하는 세포사멸 신호전달을 차단하였을 뿐만 아니라 DNA fragmentation, necrotic cell death 및 mitochondrial dysfunction을 개선시켰다. 마지막으로 암세포에서 iridin의 효과를 확인해본 결과, 폐암세포주인 NCI-H1229 세포에서 doxorubicin의 항암효과를 억제하는 경향이 나타났지만 대장암 세포주인 HCT-116 세포주에서는 암세포에 대한 성장억제를 방해하지 않는 것으로 확인되었다. 따라서 폐암세포에서 doxorubicin과 iridin의 병용처리는 힘들다고 판단되고, In vivo 수준에서 신장 독성 및 대장암 관련 실험을 통해 iridin의 역할을 추가적으로 확인해야한다고 생각된다.

Keywords

References

  1. Choi, K.M., J.H. Lee, G.O. Adam, S.J. Kim, H.S. Kang, Y.S. Yang and G.B. Kim. 2017. Effects of the Jinan red ginseng extract treatment on poloxamer 407-induced hyperlipidemia in rabbits. Korean J. Plant Res. 30:601-611.
  2. Eom, T.H., J.H. Kim, S.I. Lee and J.G. Jeong. 2013. A herbalogical study on the plants of Iridaceae in Korea. Korean J Herbol. 28:85-93. https://doi.org/10.6116/kjh.2013.28.3.85
  3. Guo, H.F. and M.H. Wang. 2017. Anti-inflammatory and anti- cancer effect of Stachys affinis tubers. Korean J. Plant Res. 30:679-685.
  4. Kim, Y.S. and J.H. Cho. 2016. Optimal treatment of advanced pancreatic neuroendocrine tumor. Korean J Pancreas Biliary Tract. 21:128-137. https://doi.org/10.15279/kpba.2016.21.3.128
  5. Lee, J.H., C.H. Lee, G.W. Park and C.Y. Song. 2007. Effect of forcing date and temperature on growth and flowering of Iris koreana and Iris minutoaurea. J Korean For Soc. 96:699-704.
  6. Lee, H.J. and S.J. Park. 2013. A phylogenetic study of Korean Iris L. based on pastid DNA (psbA-trnH, trnL-F) sequences. Korean J PI Taxon. 43:227-235. https://doi.org/10.11110/kjpt.2013.43.3.227
  7. Marcos, M. 2014. Cyclin-dependent kinases. Genome Biol. 15:122. https://doi.org/10.1186/gb4184
  8. Park, H.J., S.J. Jin, Y.N. Oh, S.G. Yun, J.Y. Lee, H.J. Kwon and B.W. Kim. 2013. Induction of G1 arrest by methanol extract of Lycopus lucidus in human lung adenocarcinoma A549 cells. J Life Sci. 23:1109-1117. https://doi.org/10.5352/JLS.2013.23.9.1109
  9. Pi, J.H., J.G. Park, J.Y. Jung, J.S. Park, G.U. Suh and S.W. Son. 2016A. Habitats environmental and population characteristics of Iris koreana Nakia, a rare and endemic species in Korea. J Agric & Life Sci. 49:102-109.
  10. Pi, J.H., J.G. Park, J.Y. Jung, J.S., Park, H.H., Yang, G.U., Suh, C.H. Lee and S.W. Son. 2016B. Vegetation structure and flora of Iris koreana Nakia, endemic species in Korea. J Agric & Life Sci. 50:55-67.
  11. Park, G.H., H.M Song, S.B. Park, J.H. Park, M.S. Shin, H.J. Son, Y. Um and J.B. Jeong. 2017. Anti-proliferative activity of ethanol extracts from Taxilli ramulus (Taxillus chinensis (DC.) Danser) through cyclin D1 proteasomal degradation in human colorectal cancer cells. Korean J. Plant Res. 30:640-646.
  12. Shin, H.J., H.K. Kwon, J.H. Lee, X. Gui, A. Achek, J.H. Kim and S. Choi. 2015. Doxorubicin-induced necrosis is mediated by poly (ADP-ribose)polymerase 1 (PARP1) but is independent of p53. Sci Rep. 5:15798. https://doi.org/10.1038/srep15798
  13. Thorn, C.F., C. Oshiro, S. Marsh, T. Hernandez-Boussard, H. Mcleod, T.E. Klein and R.B. Altman. 2011. Doxorubicin pathways: pharmacodynamics and adverse effects. Phamacogenet Genomics 21:440-446. https://doi.org/10.1097/FPC.0b013e32833ffb56
  14. Tacar, O., P. Sriamornsak and C.R. Dass. 2013. Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol. 65:157-170. https://doi.org/10.1111/j.2042-7158.2012.01567.x
  15. Tarasewicz, E., R. Hamdan, J. Straehla, A. Hardy, O. Nunez, S. Zelivianski, D. Dokic and J.S. Jeruss. 2014. CDK4 inhibition and doxorubicin mediate breast cancer cell apoptosis through Smad3 and survivin. Cancer Biol Ther. 15:1301-1311. https://doi.org/10.4161/cbt.29693
  16. Tadesse, S., M. Yu, M. Kumarasiri, B.T. Le and S. Wang. 2015. Targeting CDK6 in cancer: State of the art and new insights. Cell Cycle 14:3220-3230. https://doi.org/10.1080/15384101.2015.1084445
  17. Yoon, G.A., S.Y. Chae and K.H. Kim. 2012. Synergistic anticancer activity on mouse sarcoma by mixture of doxorubicin and water extract of Albizzia julibrissin. Cancer Prev Res. 17:239-243.
  18. Yoon, J.H., S.H. Sohn, E.Y. Lee, G.S. Kim, S.E. Lee, D.Y. Lee, K.H. Seo, S.W. Lee and H.D. Kim. 2015. Protective effect of saururus chinensis ethanol extract against styrene in mouse spermatocyte cell line. Korean J Med Crop Sci. 25:45-51.
  19. Yuan, J., A. Najafov and B.F. Py. 2016. Roles of caspases in necrotic cell death. Cell 15:1693-1704.